Cardiovascular Health: L-carnitine promotes heart health by supporting efficient fat metabolism within the heart muscles, potentially improving overall cardiovascular endurance
Analyses of antioxidant status and nucleotide alterations in genes encoding antioxidant enzymes in patients with benign and malignant thyroid disorders
Key mechanisms of GLP-1 medications include: stimulation of insulin secretion when blood glucose levels are elevated reduction of glucagon production delayed gastric emptying appetite suppression and reduced caloric intake Together, these effects contribute to improved metabolic control, weight reduction, and better cardiometabolic outcomes
Glutathione is considered to be one of the bodys most powerful antioxidants, involved in a number of enzyme systems necessary for detoxification, the neutralization of free radicals and maintaining blood-brain barrier function
Liraglutide (Saxenda, Novo Nordisk Inc) is a GLP-1 RA used as an injection treatment for weight management
What medical comorbidities are associated with NAFLD